| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/05/2009 | WO2009015623A1 Biological effect monitoring by means of transgenic hydra |
| 02/05/2009 | WO2009015602A1 Polypeptides having anticancer activity |
| 02/05/2009 | WO2009015479A1 Genetic variation in pro-melanin-concentrating hormone gene affects carcass traits in cattle |
| 02/05/2009 | WO2008145865A3 Mutated hyperthermophilic phosphotriesterases and uses thereof |
| 02/05/2009 | WO2008143666A3 Crystal structures of neuropilin fragments and neuropilin-antibody complexes |
| 02/05/2009 | WO2008141786A3 Peptides having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases |
| 02/05/2009 | WO2008140812A3 Compositions and methods comprising klk3, psca, or folh1 antigen |
| 02/05/2009 | WO2008135972A3 Glycan modified soluble receptors and binding proteins and their use |
| 02/05/2009 | WO2008104890A3 Compositions and methods for producing apolipoprotein |
| 02/05/2009 | WO2008059043A3 Combination of coagulation factor viii with apc-resistant factor v |
| 02/05/2009 | WO2008054726A3 Targeting nbs1-atm interaction to sensitize cancer cells to radiotherapy and chemotherapy |
| 02/05/2009 | WO2006120678A3 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 02/05/2009 | US20090038033 Wood and cell wall gene microarray |
| 02/05/2009 | US20090038022 IGF-1 Novel peptides |
| 02/05/2009 | US20090038020 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies |
| 02/05/2009 | US20090036656 Method for preparing a biomaterial |
| 02/05/2009 | US20090036654 Crystal structure of Rho-kinase I kinase domain complexes and binding pockets thereof |
| 02/05/2009 | US20090036648 EGVI Endoglucanase and Nucleic Acids Encoding the Same |
| 02/05/2009 | US20090036647 BITORAN WHICH IS TRYPSIN-INHIBITOR-LIKE PROTEIN DERIVED FROM BITIS ARIETANS VENOM, AND USE THEREOF AS BLOOD COAGULATION FACTOR Xa INHIBITOR |
| 02/05/2009 | US20090036537 Aromatic triamide-lanthanide complexes |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036454 Compounds and Uses Thereof |
| 02/05/2009 | US20090036431 Cytotoxic Agents Comprising New Tomaymycin Derivatives |
| 02/05/2009 | US20090036398 Human G-Protein Coupled Receptor (HETGQ23) |
| 02/05/2009 | US20090036394 GRP 146 Receptor |
| 02/05/2009 | US20090036382 TGF-Beta Modulators and Use Thereof |
| 02/05/2009 | US20090036381 Treatment of diabetes |
| 02/05/2009 | US20090036379 Inhibitors of proteins from the rho-gef family |
| 02/05/2009 | US20090036378 Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis |
| 02/05/2009 | US20090036377 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells |
| 02/05/2009 | US20090036375 DBC1, a novel native inhibitor of anti-aging protein SIRT1 |
| 02/05/2009 | US20090036374 Hepatocyte growth factor receptor splice variants and methods of using same |
| 02/05/2009 | US20090036373 a Wnt pathway stimulator and a Tie2 pathway repressor; polypeptides |
| 02/05/2009 | US20090036370 Leukocyte Adhesion Inhibitor-1 (LAI-1) |
| 02/05/2009 | US20090036367 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 02/05/2009 | US20090036366 Inhibitors of human plasmin derived from the kunitz domains |
| 02/05/2009 | US20090036365 Inhibitors of human plasmin derived from the kunitz domains |
| 02/05/2009 | US20090036364 Gip analog and hybrid polypeptides with selectable properties |
| 02/05/2009 | US20090036363 Peptides as cell penetrating carriers |
| 02/05/2009 | US20090036360 Medicament containing activated antithrombin iii |
| 02/05/2009 | US20090036358 Methods of preparing pharmaceutical compositions for treatment of factor Vlll associated disorders and methods of use |
| 02/05/2009 | US20090036353 Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers |
| 02/05/2009 | US20090036349 Methods and Compositions Related to Targeting Wounds, Regenerating Tissue, and Tumors |
| 02/05/2009 | US20090036307 Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria |
| 02/05/2009 | US20090035853 Tsg101-gag interaction and use thereof |
| 02/05/2009 | US20090035822 Fusion Proteins |
| 02/05/2009 | US20090035821 Expression of Proteins in E.Coli |
| 02/05/2009 | US20090035819 CA125 gene and its use for diagnostic and therapeutic interventions |
| 02/05/2009 | US20090035818 Novel Polypeptide, Polynucleotide Encoding the Polypeptide and Use the Polypeptide and Polynucleotide |
| 02/05/2009 | US20090035814 Method for producing circular or multimeric protein species in vivo or in vitro and related methods |
| 02/05/2009 | US20090035799 Novel trypsin family serine proteases |
| 02/05/2009 | US20090035788 Genetically encoded bioindicators of calcium-ions |
| 02/05/2009 | US20090035784 Npc1l1 and npc1l1 inhibitors and methods of use thereof |
| 02/05/2009 | US20090035783 Fluorescent proteins and uses thereof |
| 02/05/2009 | US20090035771 gene expression; probes, primers, antibodies |
| 02/05/2009 | US20090035753 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| 02/05/2009 | US20090035747 Nucleic Acid and Gene Derived from Novel HCV Strain and Replicon-Replicating Cell Using Said Gene |
| 02/05/2009 | US20090035437 Whey protein micelles |
| 02/05/2009 | US20090035359 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 02/05/2009 | US20090035356 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 02/05/2009 | US20090035347 Isolated stromal cells and methods of using the same |
| 02/05/2009 | US20090035321 Intercellular adhesion molecules and their binding ligands |
| 02/05/2009 | US20090035317 Peptides binding to vascular endothelial growth factor |
| 02/05/2009 | US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC) |
| 02/05/2009 | US20090035312 Tumor angiogenesis associated genes and a method for their identification |
| 02/05/2009 | US20090035301 Methods for diagnosing and treating bladder cancer |
| 02/05/2009 | US20090035300 Immunomodulation of dendritic cells |
| 02/05/2009 | US20090035299 Methods and compositions for treating diseases targeting MABA1 |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | US20090035295 Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said Antibodies |
| 02/05/2009 | US20090035287 Atrial natriuretic peptide (anp) splice variants and methods of using same |
| 02/05/2009 | US20090035278 Reoviruses having modified sequences |
| 02/05/2009 | US20090035275 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of NAD |
| 02/05/2009 | US20090035264 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities |
| 02/05/2009 | US20090035261 for treating degenerative cartilaginous disorders and other inflammatory diseases; inhibiting the proliferation of T-lymphocytes; modulating infiltration of inflammatory cells into a tissue of a mammal |
| 02/05/2009 | US20090035259 Group a streptococcal vaccines |
| 02/05/2009 | US20090035256 Modified interleukin 10 polypeptide for use in treatment and prevention of neuropathic pain, neurological and inflammatory disorders |
| 02/05/2009 | US20090035255 Conjugate for targeting of drug |
| 02/05/2009 | US20090035254 IL-21 Variants |
| 02/05/2009 | US20090035252 Method of inducing a CTL response |
| 02/05/2009 | US20090035215 Radiofluorination |
| 02/05/2009 | DE102007030904A1 Humanes zirkulierendes antivirales Albumin-Fragment (ALB-408) und seine Verwendung Human circulating antiviral albumin fragment (ALB-408) and its use |
| 02/05/2009 | CA2817054A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2723139A1 Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells |
| 02/05/2009 | CA2705046A1 Process for the preparation glatiramer acetate (copolymer-1) |
| 02/05/2009 | CA2700004A1 Novel immunotherapy strategy |
| 02/05/2009 | CA2700000A1 Diagnostic assay for trypanosoma cruzi infection |
| 02/05/2009 | CA2697127A1 Adeno-associated viral vectors for the expression of dysferlin |
| 02/05/2009 | CA2695384A1 Bi-dentate compounds as kinase inhibitors |
| 02/05/2009 | CA2695361A1 Collagen-related peptides |
| 02/05/2009 | CA2695360A1 Diagnosis, staging and monitoring of inflammatory bowel disease |
| 02/05/2009 | CA2695288A1 Collagen-related peptides and uses thereof |
| 02/05/2009 | CA2695169A1 Compositions comprising pneumococcal antigens |
| 02/05/2009 | CA2694805A1 Immunogenic epitopes of tumour-associated antigens |
| 02/05/2009 | CA2694718A1 Genetic variation in pro-melanin-concentrating hormone gene affects carcass traits in cattle |
| 02/05/2009 | CA2694542A1 Method for producing peptide |
| 02/05/2009 | CA2694453A1 Optimized purification process of recombinant growth factor protein |
| 02/05/2009 | CA2694142A1 Transgenic plants with increased stress tolerance and yield |
| 02/05/2009 | CA2694139A1 New compositions, methods and uses |
| 02/05/2009 | CA2694127A1 Idiotypic vaccine |